These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 19608940)

  • 1. Planning for posttrial access to antiretroviral treatment for research participants in developing countries.
    Shah S; Elmer S; Grady C
    Am J Public Health; 2009 Sep; 99(9):1556-62. PubMed ID: 19608940
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Access to medications and medical care after participation in HIV clinical trials: a systematic review of trial protocols and informed consent documents.
    Ciaranello AL; Walensky RP; Sax PE; Chang Y; Freedberg KA; Weissman JS
    HIV Clin Trials; 2009; 10(1):13-24. PubMed ID: 19362992
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The obligation to provide antiretroviral treatment in HIV prevention trials.
    Lo B; Padian N; Barnes M
    AIDS; 2007 Jun; 21(10):1229-31. PubMed ID: 17545698
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Access to antiretroviral treatment in developing countries: Which financing strategies are possible?
    Beaulière A; Le Maux A; Trehin C; Perez F
    Rev Epidemiol Sante Publique; 2010 Jun; 58(3):171-9. PubMed ID: 20430553
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Community perspectives on care options for HIV prevention trial participants.
    MacQueen KM; Namey E; Chilongozi DA; Mtweve SP; Mlingo M; Morar N; Reid C; Ristow A; Sahay S;
    AIDS Care; 2007 Apr; 19(4):554-60. PubMed ID: 17453597
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Monitoring of HIV treatment in seven countries in the WHO Region of the Americas.
    Belaunzarán-Zamudio PF; Caro-Vega YN; Shepherd BE; Crabtree-Ramírez BE; Luz PM; Grinsztejn B; Cesar C; Cahn P; Cortés C; Wolff M; Pape JW; Padgett D; Gotuzzo E; McGowan C; Sierra-Madero JG;
    Bull World Health Organ; 2015 Aug; 93(8):529-39. PubMed ID: 26478610
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Free care at the point of service delivery: a key component for reaching universal access to HIV/AIDS treatment in developing countries.
    Souteyrand YP; Collard V; Moatti JP; Grubb I; Guerma T
    AIDS; 2008 Jul; 22 Suppl 1():S161-8. PubMed ID: 18664948
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Financing equitable access to antiretroviral treatment in South Africa.
    Cleary S; McIntyre D
    BMC Health Serv Res; 2010 Jul; 10 Suppl 1(Suppl 1):S2. PubMed ID: 20594368
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulatory impediments jeopardizing the conduct of clinical trials in Europe funded by the National Institutes of Health.
    Neaton JD; Babiker A; Bohnhorst M; Darbyshire J; Denning E; Frishman A; Grarup J; Larson G; Lundgren J
    Clin Trials; 2010 Dec; 7(6):705-18. PubMed ID: 20729252
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Outcomes of antiretroviral therapy in children in Asia and Africa: a comparative analysis of the IeDEA pediatric multiregional collaboration.
    Leroy V; Malateste K; Rabie H; Lumbiganon P; Ayaya S; Dicko F; Davies MA; Kariminia A; Wools-Kaloustian K; Aka E; Phiri S; Aurpibul L; Yiannoutsos C; Signaté-Sy H; Mofenson L; Dabis F;
    J Acquir Immune Defic Syndr; 2013 Feb; 62(2):208-19. PubMed ID: 23187940
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term immunologic response to antiretroviral therapy in low-income countries: a collaborative analysis of prospective studies.
    Nash D; Katyal M; Brinkhof MW; Keiser O; May M; Hughes R; Dabis F; Wood R; Sprinz E; Schechter M; Egger M;
    AIDS; 2008 Nov; 22(17):2291-302. PubMed ID: 18981768
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Universal antiretroviral therapy for HIV infection: should US treatment guidelines be applied to resource-limited settings?
    Gallant JE; Mehta SH; Sugarman J
    Clin Infect Dis; 2013 Sep; 57(6):884-7. PubMed ID: 23759345
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multi-country analysis of treatment costs for HIV/AIDS (MATCH): facility-level ART unit cost analysis in Ethiopia, Malawi, Rwanda, South Africa and Zambia.
    Tagar E; Sundaram M; Condliffe K; Matatiyo B; Chimbwandira F; Chilima B; Mwanamanga R; Moyo C; Chitah BM; Nyemazi JP; Assefa Y; Pillay Y; Mayer S; Shear L; Dain M; Hurley R; Kumar R; McCarthy T; Batra P; Gwinnell D; Diamond S; Over M
    PLoS One; 2014; 9(11):e108304. PubMed ID: 25389777
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adherence to antiretroviral therapy in adolescents living with HIV: systematic review and meta-analysis.
    Kim SH; Gerver SM; Fidler S; Ward H
    AIDS; 2014 Aug; 28(13):1945-56. PubMed ID: 24845154
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cost-effectiveness of early versus standard antiretroviral therapy in HIV-infected adults in Haiti.
    Koenig SP; Bang H; Severe P; Jean Juste MA; Ambroise A; Edwards A; Hippolyte J; Fitzgerald DW; McGreevy J; Riviere C; Marcelin S; Secours R; Johnson WD; Pape JW; Schackman BR
    PLoS Med; 2011 Sep; 8(9):e1001095. PubMed ID: 21949643
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The macroeconomic consequences of renouncing to universal access to antiretroviral treatment for HIV in Africa: a micro-simulation model.
    Ventelou B; Arrighi Y; Greener R; Lamontagne E; Carrieri P; Moatti JP
    PLoS One; 2012; 7(4):e34101. PubMed ID: 22514619
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ethical imperative of posttrial access to antiretroviral treatment.
    Onyeabor OS
    Am J Public Health; 2010 Jun; 100(6):966-7; author reply 967. PubMed ID: 20395568
    [No Abstract]   [Full Text] [Related]  

  • 18. The HIV Treatment Gap: Estimates of the Financial Resources Needed versus Available for Scale-Up of Antiretroviral Therapy in 97 Countries from 2015 to 2020.
    Dutta A; Barker C; Kallarakal A
    PLoS Med; 2015 Nov; 12(11):e1001907; discussion e1001907. PubMed ID: 26599990
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Barriers to access to antiretroviral treatment in developing countries: a review.
    Posse M; Meheus F; van Asten H; van der Ven A; Baltussen R
    Trop Med Int Health; 2008 Jul; 13(7):904-13. PubMed ID: 18466183
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reciprocity and post-trial access for participants in antiretroviral therapy trials.
    Merritt M; Grady C
    AIDS; 2006 Sep; 20(14):1791-4. PubMed ID: 16954719
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.